Cytochrome P450-Mediated Interactions of Monoclonal Antibodies and Small-Molecules Drugs

Clinical pharmacology and therapy
doi 10.32756/0869-5490-2019-4-43-49
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmapress LLC

Related search

Mechanism of Drug–Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer

Biochemistry
Biochemistry
2015English

Cytochrome P450 Drug Interactions With Statin Therapy

Singapore Medical Journal
Medicine
2013English

Retraction: Role of Cytochrome P450 in Drug Interactions

Nutrition and Metabolism
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2014English

Influence of Transmembrane Helix Mutations on Cytochrome P450-Membrane Interactions and Function

Biophysical Journal
Biophysics
2019English

Genetically Engineered Bacterial Cells Co-Expressing Human Cytochrome P450 With NADPH-cytochrome P450 Reductase: Prediction of Metabolism and Toxicity of Drugs in Humans

Drug Metabolism and Pharmacokinetics
PharmacologyPharmaceutical Science
2002English

Current Approaches for Investigating and Predicting Cytochrome P450 3a4-Ligand Interactions

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2015English

Structures of Cytochrome P450 17A1 With Prostate Cancer Drugs Abiraterone and TOK-001

Nature
Multidisciplinary
2012English

Direct Single-Step Surface Plasmon Resonance Analysis of Interactions Between Small Peptides and Immobilized Monoclonal Antibodies

Journal of Immunological Methods
AllergyImmunology
2000English

Secobarbital-Mediated Inactivation of Cytochrome P450 2B1 and Its Active Site Mutants

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy